By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Mar 15, 2022/CPG
This comprehensive guideline, sponsored by the Reflex Sympathetic Dystrophy Syndrome Association, includes a section on physical therapy management as well as general considerations.
Aug 13, 2019/CPG
This guideline presents recommendations for the care and management of adult (age 25-44 years) inpatients at risk of developing deep vein thrombosis (DVT).
Apr 5, 2023/CPG
This guideline provides recommendations related to the diagnosis and management of early and locally advanced breast cancer.
Dec 1, 2019/CPG
This guideline provides recommendations for the prevention and management of pressure ulcers in patients of all ages.
Nov 1, 2016/CPG
This guideline provides recommendations reated to the diagnostic utility of imaging for infants with suspected positional plagiocephaly.
This guideline provides a summary of the effectiveness of helmet therapy as a treatment for positional plagiocephaly.
Mar 23, 2021/CPG
Recommendations for managing COVID‑19 symptoms for patients in the community -- babies, children, young people, and adults in all care settings, including at the end of life.
May 1, 2020/CPG
These guidelines address the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children, including new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.
Appraisal ratings for clinical practice guidelines (CPGs) posted on PTNow are generated by 3 or more physical therapists trained in using the Appraisal of Guidelines for Research and Evaluation II (AGREE II).
Nov 11, 2021/CPG
This "living" guideline covers identifying, assessing, and managing the long-term effects of COVID-19, frequently described as "long COVID." It makes recommendations about care in all health care settings for adults, children, and young people who have new or ongoing symptoms lasting four weeks or more